Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Halozyme Therapeutics
(HALO) Q2 2014
Earnings
HALO
May 12
Confirmed
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-0.22
-0.19
-0.17
-0.14
Details
Expected EPS
-0.14
Actual EPS
-0.22
Surprise EPS
-0.08
Surprise Percent
-57.14%
Description
Halozyme Therapeutics (HALO) has reported earnings of -0.22 per share for Q2 2014.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login